Atossa Genetics Inc (NASDAQ:ATOS)
| 1.43 Delayed Data As of Dec 13 |  +0.0399 / +2.87%Today’s Change | 0.80 Today|||52-Week Range 7.39 | +40.20% Year-to-Date |
Latest ATOS News | Press Releases
No recent news for Atossa Genetics Inc.
Today’s Trading
| Previous close | 1.39 |
| Today’s open | 1.41 |
| Day’s range | 1.38 - 1.43 |
| Volume | 41,256 |
| Average volume (3 months) | 104,891 |
| Market cap | $12.7M |
Data as of 3:58pm ET, 12/13/2019
Growth & Valuation
| Earnings growth (last year) | +49.60% |
| Earnings growth (this year) | +47.64% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.27 |
Competitors
| ---- | ||
| NVLNFNovelion Therapeutic... | -0.02 | -2.60% |
| MTPMidatech Pharma PLC | -0.01 | -2.05% |
| CYANCyanotech Corp | -0.08 | -3.43% |
Data as of 3:58pm ET, 12/13/2019
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$11.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Seattle, Washington |
Forecasts
